Free Trial

Alpha Teknova Q2 2023 Earnings Report

Alpha Teknova logo
$5.19 0.00 (0.00%)
As of 04:00 PM Eastern

Alpha Teknova EPS Results

Actual EPS
-$0.25
Consensus EPS
-$0.26
Beat/Miss
Beat by +$0.01
One Year Ago EPS
N/A

Alpha Teknova Revenue Results

Actual Revenue
$11.53 million
Expected Revenue
$9.60 million
Beat/Miss
Beat by +$1.93 million
YoY Revenue Growth
N/A

Alpha Teknova Announcement Details

Quarter
Q2 2023
Time
N/A

Conference Call Resources

Conference Call Audio

Slide Deck

Remove Ads

Alpha Teknova Earnings Headlines

Elon Tax Shock?
Elon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax authorities have bought a powerful new AI supercomputer, worth millions of dollars. It's the most advanced technology offered by AI giant Nvidia. And it's almost certainly going to be used to advance Elon Musk's real agenda with DOGE... the massive, rapid roll out of AI across the entire federal government.
See More Alpha Teknova Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Alpha Teknova? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Alpha Teknova and other key companies, straight to your email.

About Alpha Teknova

Alpha Teknova (NASDAQ:TKNO) produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.

View Alpha Teknova Profile

More Earnings Resources from MarketBeat